These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 11155733

  • 1. [Antibiotic management of acute otitis media. New recommendations].
    Longuet P.
    Presse Med; 2000 Dec 02; 29(37):2049-50. PubMed ID: 11155733
    [Abstract] [Full Text] [Related]

  • 2. Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.
    Easton J, Noble S, Perry CM.
    Drugs; 2003 Dec 02; 63(3):311-40. PubMed ID: 12534334
    [Abstract] [Full Text] [Related]

  • 3. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Ghaffar F, Muniz LS, Katz K, Reynolds J, Smith JL, Davis P, Friedland IR, McCracken GH.
    Clin Infect Dis; 2000 Oct 02; 31(4):875-80. PubMed ID: 11049764
    [Abstract] [Full Text] [Related]

  • 4. In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae.
    Parra A, Ponte C, Cenjor C, García-Olmos M, Giménez MJ, Aguilar L, Soriano F.
    Int J Antimicrob Agents; 2004 Jan 02; 23(1):25-31. PubMed ID: 14732310
    [Abstract] [Full Text] [Related]

  • 5. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A, Aguilar L, Robledo O, Giménez MJ, Tarragó D, Granizo JJ, Gimeno M, Coronel P.
    J Antimicrob Chemother; 2007 Aug 02; 60(2):323-7. PubMed ID: 17562681
    [Abstract] [Full Text] [Related]

  • 6. Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children.
    Sher L, Arguedas A, Husseman M, Pichichero M, Hamed KA, Biswas D, Pierce P, Echols R.
    Pediatr Infect Dis J; 2005 Apr 02; 24(4):301-8. PubMed ID: 15818288
    [Abstract] [Full Text] [Related]

  • 7. Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
    Soriano F, Parra A, Cenjor C, Nieto E, García-Calvo G, Giménez MJ, Aguilar L, Ponte C.
    J Infect Dis; 2000 Feb 02; 181(2):646-52. PubMed ID: 10669350
    [Abstract] [Full Text] [Related]

  • 8. Recurrent and persistent otitis media.
    Pichichero ME.
    Pediatr Infect Dis J; 2000 Sep 02; 19(9):911-6. PubMed ID: 11001126
    [Abstract] [Full Text] [Related]

  • 9. Amoxicillin/clavulanate for infections in infants and children: past, present and future.
    Klein JO.
    Pediatr Infect Dis J; 2003 Aug 02; 22(8 Suppl):S139-48. PubMed ID: 14567000
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain.
    Isla A, Trocóniz IF, Canut A, Labora A, Martín-Herrero JE, Pedraz JL, Gascón AR.
    Enferm Infecc Microbiol Clin; 2011 Mar 02; 29(3):167-73. PubMed ID: 21334779
    [Abstract] [Full Text] [Related]

  • 11. Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean children.
    Casellas JM, Israele V, Marín M, Ishida MT, Heguilen R, Soutric J, Arenoso H, Sibbald A, Stamboulian D.
    Int J Pediatr Otorhinolaryngol; 2005 Sep 02; 69(9):1225-33. PubMed ID: 16061111
    [Abstract] [Full Text] [Related]

  • 12. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B.
    J Antimicrob Chemother; 2004 Jan 02; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [Abstract] [Full Text] [Related]

  • 13. Eradication of pathogens from the nasopharynx after therapy of acute maxillary sinusitis with low- or high-dose amoxicillin/clavulanic acid.
    Brook I, Foote PA, Hausfeld JN.
    Int J Antimicrob Agents; 2005 Nov 02; 26(5):416-9. PubMed ID: 16226017
    [Abstract] [Full Text] [Related]

  • 14. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
    Aggarwal M, Sinha R, Murali MV, Trihan P, Singhal PK.
    Indian J Pediatr; 2005 Mar 02; 72(3):233-8. PubMed ID: 15812119
    [Abstract] [Full Text] [Related]

  • 15. Achieving bacterial eradication using pharmacokinetic/pharmacodynamic principles.
    Dagan R.
    Int J Infect Dis; 2003 Mar 02; 7 Suppl 1():S21-6. PubMed ID: 12839704
    [Abstract] [Full Text] [Related]

  • 16. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children.
    Cohen R, Bingen E, Varon E, de La Rocque F, Brahimi N, Levy C, Boucherat M, Langue J, Geslin P.
    Pediatr Infect Dis J; 1997 Jun 02; 16(6):555-60. PubMed ID: 9194104
    [Abstract] [Full Text] [Related]

  • 17. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
    Piglansky L, Leibovitz E, Raiz S, Greenberg D, Press J, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 2003 May 02; 22(5):405-13. PubMed ID: 12792379
    [Abstract] [Full Text] [Related]

  • 18. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media.
    Dagan R.
    Int J Antimicrob Agents; 2007 Dec 02; 30 Suppl 2():S127-30. PubMed ID: 17980558
    [Abstract] [Full Text] [Related]

  • 19. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE, Gurwith MJ.
    Clin Pharm; 1984 Dec 02; 3(6):591-9. PubMed ID: 6391783
    [Abstract] [Full Text] [Related]

  • 20. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM, Jacobs MR, Good CE, Bajaksouzian S, Windau A, Jakielaszek C, Saunders KA.
    Int J Infect Dis; 2004 Nov 02; 8(6):362-73. PubMed ID: 15494258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.